| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 07/11/2013 | WO2013103781A1 Biomarkers for diagnosing ischemia |
| 07/11/2013 | WO2013103744A1 Improved dna polymerase activity assays and methods enabling detection of viable microbes |
| 07/11/2013 | WO2013103737A1 Methods and compounds for increasing sensitivity of botulinum assays |
| 07/11/2013 | WO2013103712A1 Methods for measuring protein content |
| 07/11/2013 | WO2013103637A1 Analysis and targeting of ror2 in cancer |
| 07/11/2013 | WO2013103628A1 Peptides and methods for detecting mpo-anca |
| 07/11/2013 | WO2013103512A1 Systems genetics network regulators as drug targets |
| 07/11/2013 | WO2013103360A1 Isothermal nucleic acid amplification reactor with integrated solid state membrane |
| 07/11/2013 | WO2013103245A1 Multimer type discrimination and detection method for multimer-forming polypeptide |
| 07/11/2013 | WO2013103226A1 Marker for early diagnosis of diabetic retinopathy and usage for same |
| 07/11/2013 | WO2013103225A1 Marker for early diagnosis of diabetic retinopathy and usage of same |
| 07/11/2013 | WO2013103197A1 Cancer diagnosis device |
| 07/11/2013 | WO2013102949A1 Image processing method, image processing device, image processing program, and memory medium |
| 07/11/2013 | WO2013102916A1 Prediction of refining characteristics of oil |
| 07/11/2013 | WO2013102786A1 Enhancement of sensitivity and specificity of ketosteroids and keto or aldehyde containing analytes |
| 07/11/2013 | WO2013102757A1 Diagnostic method and system |
| 07/11/2013 | WO2013102688A1 Method for determining inositol phosphates and the use thereof in kit form |
| 07/11/2013 | WO2013102681A1 Method and system for indentifying compounds that bind and/or activate a target opioid receptor in a ph-dependent manner |
| 07/11/2013 | WO2013102641A1 Means and methods for treating or diagnosing idh1 r132h mutant-positive cancers |
| 07/11/2013 | WO2013102627A1 Methods for the detection and the treatment of diastolic dysfunction |
| 07/11/2013 | WO2013102458A1 Method for producing an examination reagent and kit for analysing a t-cell frequency |
| 07/11/2013 | WO2013102448A1 Biosensor and biomeasurement system |
| 07/11/2013 | WO2013077747A3 Detection of viable endophyte |
| 07/11/2013 | WO2013074601A4 Gamma-pna miniprobes for fluorescent labeling |
| 07/11/2013 | WO2013074520A3 Detection, isolation and analysis of rare cells in biological fluids |
| 07/11/2013 | WO2013066802A3 Compositions and methods for lung regeneration |
| 07/11/2013 | WO2013066458A3 Fluorescent sensing of vapors using tubular nanofibril materials |
| 07/11/2013 | WO2013066456A3 Articles comprising templated crosslinked polymer films for electronic detection of nitroaromatic explosives |
| 07/11/2013 | WO2013063366A3 Methods for screening viral like particles and identifying neutralizing epitopes and related vaccines, constructs, and libraries |
| 07/11/2013 | WO2013063155A3 Companion diagnostic for anti-hyaluronan agent therapy and methods of use thereof |
| 07/11/2013 | WO2013052747A3 Methods and systems for configuring sensor acquisition based on pressure steps |
| 07/11/2013 | WO2013052612A3 Method and system to monitor the state and function of the cervix and effects of treatments for the cervix |
| 07/11/2013 | WO2013032689A3 Dye compositions |
| 07/11/2013 | WO2013032242A3 Target non-binding aptamer selection method using graphene and aptamer selected therefrom |
| 07/11/2013 | WO2013025679A3 Diffuse reflectance infrared fourier transform spectroscopy for characterization of earth materials |
| 07/11/2013 | WO2013012781A3 Genome-wide methylation analysis and use to identify genes specific to breast cancer hormone receptor status and risk of recurrence |
| 07/11/2013 | WO2013001369A4 Therapeutic and diagnostic target |
| 07/11/2013 | WO2012159072A3 Fluorescent molecular probes for use in assays that measure test compound competitive binding with sam-utilizing proteins |
| 07/11/2013 | WO2012158780A3 Lung cancer signature |
| 07/11/2013 | WO2012047618A3 Mesothelioma biomarkers and uses thereof |
| 07/11/2013 | WO2012017466A8 Use of hmgb1 as a biological marker of bowel inflammatory conditions, non-invasive method for its detection in fecal samples and kit thereof |
| 07/11/2013 | WO2005083429A8 Breast cancer prognostics |
| 07/11/2013 | US20130179997 Transgenic animal expressing alzheimer's tau protein |
| 07/11/2013 | US20130179092 Global crude oil quality monitoring using direct measurement and advanced analytic techniques for raw material valuation |
| 07/11/2013 | US20130178543 Biomarker for diagnosing cancer and method of isolating cancer cell using the same |
| 07/11/2013 | US20130178533 Composition for diagnosing, treating, and preventing liver disease |
| 07/11/2013 | US20130178515 Predictive markers for taxane responsiveness and methods of use thereof |
| 07/11/2013 | US20130178395 Aza-Benzazolium Containing Cyanine Dyes |
| 07/11/2013 | US20130178388 Methods and Kits for the Diagnosis of Rheumatoid Arthritis |
| 07/11/2013 | US20130178386 Platelet biomarkers for the detection of disease |
| 07/11/2013 | US20130178385 Biomarkers |
| 07/11/2013 | US20130178384 Process For Measuring Antigen Content |
| 07/11/2013 | US20130178382 Identification of Modulators of Autophagy |
| 07/11/2013 | US20130178380 O-ring systems and methods for quantification of multiplex biomarkers in multiple samples |
| 07/11/2013 | US20130178375 Methods of Detecting Neurological or Neuropsychiatric Diseases or Conditions |
| 07/11/2013 | US20130178370 Proteomic identification of antibodies |
| 07/11/2013 | US20130177996 Device and Method for Testing Biological Samples |
| 07/11/2013 | US20130177994 METHODS FOR QUANTITATIVE CHIRAL DETERMINATION OF THE d- AND l- ENANTIOMERS OF AMPHETAMINE AND METHAMPHETAMINE |
| 07/11/2013 | US20130177990 Methods of determining efficacy of cyclodextrin therapy |
| 07/11/2013 | US20130177970 Methods and compositions for detecting the activation state of multiple proteins in single cells |
| 07/11/2013 | US20130177936 Method of cancer diagnosis using the analysis of isopopes |
| 07/11/2013 | US20130177933 Characterization of Subvisible Particles Using a Particle Analyzer |
| 07/11/2013 | US20130177932 Ex-vivo method for the early diagnosis of minimal hepatic encephalopathy by means of the determination of the 3-nitrotyrosine in serum |
| 07/11/2013 | US20130177930 Methods for measuring protein content |
| 07/11/2013 | US20130177929 Method for the three-dimensional co- culture of podocytes and endothelial cells and relative in vitro co- culture system |
| 07/11/2013 | US20130177928 Normalization of platelet biomarkers |
| 07/11/2013 | US20130177927 Protein markers for esophageal cancer |
| 07/11/2013 | US20130177926 Simultaneous Assay of Target and Target-Drug Binding |
| 07/11/2013 | US20130177924 Linked peptide fluorogenic biosensors |
| 07/11/2013 | US20130177923 Diagnostic use of individual molecular forms of a biomarker |
| 07/11/2013 | US20130177921 Detection of Damage to DNA |
| 07/11/2013 | US20130177919 Protein production |
| 07/11/2013 | US20130177904 Arnt isoform 3 as a predictor of aminoflavone responsiveness in cancer cells |
| 07/11/2013 | US20130177901 Markers for the prognosis and risk assessment of pregnancy-induced hypertension and preeclampsia |
| 07/11/2013 | US20130177660 Potentiator of activity of anti-cancer agent and use thereof, and biomarker for prediction of prognosis in cancer patient and use thereof |
| 07/11/2013 | US20130177647 Methods for manipulating satiety |
| 07/11/2013 | US20130177575 Novel therapeutic target and diagnostic marker for asthma and related conditions |
| 07/11/2013 | US20130177569 Nucleic acids and corresponding proteins entitled 202p5a5 useful in treatment and detection of cancer |
| 07/11/2013 | US20130177567 Novel c3c epitope, antibodies binding thereto, and use thereof |
| 07/11/2013 | US20130177566 Methods and compositions for treating and diagnosing diseases |
| 07/11/2013 | US20130177554 Neuropilin as a biomarker for bevacizumab combination therapies |
| 07/11/2013 | US20130177551 Risk markers for cardiovascular disease |
| 07/11/2013 | US20130177544 Biomarkers associated with pre-diabetes, diabetes and diabetes related conditions |
| 07/11/2013 | US20130177214 Device, system and method for transit testing of samples |
| 07/11/2013 | US20130176551 Method and apparatus for detecting and counting platelets individually and in aggregate clumps |
| 07/11/2013 | US20130175000 Visual Quality Indicator for Aqueous Streams |
| 07/11/2013 | US20130174646 Networked air quality monitoring |
| 07/11/2013 | US20130174634 Method for decreasing variability in a moisture analyzer |
| 07/11/2013 | DE102012100115A1 Device for determining mixture ratio of liquid gas mixture, is provided with liquid gases, where the gas mixture is determined for combustion in an engine, and the gas mixture is supplied from a gas tank |
| 07/11/2013 | CA2857762A1 Methods for measuring protein content |
| 07/11/2013 | CA2764372A1 Device for quantification of biological cells |
| 07/10/2013 | EP2613277A1 Method and system for indentifying compounds that bind and preferably activate a target opioid receptor in a pH-dependent manner |
| 07/10/2013 | EP2613154A2 Process for the identification of novel enzyme interacting compounds |
| 07/10/2013 | EP2613153A2 Process for the identification of novel enzyme interacting compounds |
| 07/10/2013 | EP2613152A2 Sensitizer for an erythrocytic diagnostic agent for diagnosing malignant neoplasms and method for producing same, erythrocytic diagnostic agent for diagnosing malignant neoplasms and method for producing same and method for diagnosing the presence of malignant neoplasms using said erythrocytic diagnostic agent |
| 07/10/2013 | EP2613151A1 Method for determining cancer onset or cancer onset risk |
| 07/10/2013 | EP2613150A1 Diagnosis and treatment of preeclampsia |
| 07/10/2013 | EP2613149A1 Exosome-Associated MicroRNA as a Diagnostic Marker |
| 07/10/2013 | EP2613148A1 Methods and kits for measuring von Willebrand factor |
| 07/10/2013 | EP2613147A1 Detection methods using aptamers |